These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8572579)

  • 1. Effect on cell survival and protein synthesis of benzylidene-glucose (BG) and the deuterated analogue P-1013 in cultured cells.
    Dunsaed CB; Dornish JM; Oftebro R; Pettersen EO
    Anticancer Res; 1995; 15(5B):1921-7. PubMed ID: 8572579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on protein synthesis and cell survival of the benzaldehyde derivatives sodium benzylidene ascorbate (SBA) and the deuterated compound zilascorb(2H).
    Pettersen EO; Larsen RO; Boerretzen B; Dornish JM; Oftebro R
    Anticancer Res; 1991; 11(3):1077-81. PubMed ID: 1888141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4,6-Benzylidene-D-glucose, a benzaldehyde derivative that inhibits protein synthesis but not mitosis of NHIK 3025 cells.
    Pettersen EO; Dornish JM; Rønning OW
    Cancer Res; 1985 May; 45(5):2085-91. PubMed ID: 3986764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro modulating effect of the reversible protein synthesis inhibitor zilascorb (2H) on cis-diamminedichloroplatinum (II)-induced cytotoxicity.
    Melvik JE; Dornish JM; Larsen RO; Børretzen B; Oftebro R; Pettersen EO
    Anticancer Res; 1992; 12(1):33-8. PubMed ID: 1567178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines.
    De Vincenzo R; Scambia G; Ferlini C; Distefano M; Filippini P; Riva A; Bombardelli E; Pocar D; Gelmi ML; Benedetti Panici P; Mancuso S
    Anticancer Drug Des; 1998 Jan; 13(1):19-33. PubMed ID: 9474240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
    J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
    Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased effect of benzaldehyde by exchanging the hydrogen in the formyl group with deuterium.
    Pettersen EO; Larsen RO; Børretzen B; Dornish JM; Oftebro R
    Anticancer Res; 1991; 11(1):369-73. PubMed ID: 2018372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumour effect of benzylidene-glucose (BG) in rats with chemically induced hepatocellular carcinoma.
    Pettersen EO; Schwarze PE; Dornish JM; Nesland JM
    Anticancer Res; 1986; 6(2):147-52. PubMed ID: 3707050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invivo pharmacokinetics of the antitumor agent 4,6-benzylidene-d-glucose (bg) and a deuterated analog 4,6-benzylidene-d1-d-glucose (p-1013) in mice, rats and dogs.
    Dunsaed C; Dornish J; Aastveit T; Pettersen E
    Int J Oncol; 1993 Jan; 2(1):61-6. PubMed ID: 21573515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Prinz H; Ishii Y; Hirano T; Stoiber T; Camacho Gomez JA; Schmidt P; Düssmann H; Burger AM; Prehn JH; Günther EG; Unger E; Umezawa K
    J Med Chem; 2003 Jul; 46(15):3382-94. PubMed ID: 12852768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a benzaldehyde derivative.
    Kochi M; Isono N; Niwayama M; Shirakabe K
    Cancer Treat Rep; 1985 May; 69(5):533-7. PubMed ID: 4005876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines.
    Bonovich M; Olive M; Reed E; O'Connell B; Vinson C
    Cancer Gene Ther; 2002 Jan; 9(1):62-70. PubMed ID: 11916245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
    J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell-lines.
    Cheng SC; Zhou J; Xie Y
    Cell Biol Int; 2005 Apr; 29(4):269-75. PubMed ID: 15914037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
    Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH
    Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bioavailability and dose dependency of the deuterated anti-tumour agent 4,6-benzylidene-d1-D-glucose in mice and rats.
    Dunsaed CB; Dornish JM; Pettersen EO
    Cancer Chemother Pharmacol; 1995; 35(6):464-70. PubMed ID: 7882455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.